Dyne Therapeutics, Inc.

DYN· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$16.69-2.05%

2026-10-30

Financials

Valuation Metrics

Dyne Therapeutics, Inc.'s Market Cap is $3.12B. At end of 2025 it was $2.51B. Ranked #1671 of 3,115 in US market (top 54%), #593 of 1,472 on NASDAQ (top 40%), #99 of 265 in Pharmaceuticals, Biotechnology & Life Sciences (top 37%) by Market Cap.

Investment Metrics(as of 2026-10-30)

Metric	Value	Rank
Size
Market Cap	$3.12B	US#1,671/3,115 Sec#99/265
Revenue	$0.00	US#2,861/3,115 Sec#193/265
Net Income	$-519M	US—/3,115 Sec—/265
Total Assets	$994M	US#2,477/3,115 Sec#103/265
Net Assets	$702M	US#1,999/3,115 Sec#86/265
Value
P/B	4.44x	US#2,133/3,115 Sec#136/265
FCF Yield	-16.02%	US—/3,115 Sec—/265
Profitability
ROE	-73.97%	US#2,754/3,115 Sec#193/265
ROA	-52.25%	US#2,993/3,115 Sec#218/265
Financial Health
Debt Ratio	41.57%	US#475/3,115 Sec#130/265
Total Debt	$20M	US#2,751/3,115 Sec#189/265
FCF	$-499M	US#2,908/3,115 Sec#253/265
Cash	$676M	US#885/3,115 Sec#42/265
Current Ratio	12.02x	US#203/3,115 Sec#62/265
Performance
1Y Return	-29.13%	US#2,570/3,115 Sec#211/265
1M Return	3.60%	US#1,166/3,115 Sec#84/265
From 52W High	-38.89%	US#2,311/3,115 Sec#167/265
1Y MDD	-46.79%	US#2,265/3,115 Sec#149/265
Trading
Volume	1,130,737 shares	US#863/3,115 Sec#75/265
Trading Value	$19M	US#1,548/3,115 Sec#115/265
Per Share
EPS	$-2.78	US—/3,115 Sec—/265
BPS	$3.76	US#2,381/3,115 Sec#143/265